$BLLN

Sakakibara Shan Riku sold $561K of BLLN

Sakakibara Shan Riku (Chief Product Officer) sold 4,000 shares of BillionToOne, Inc. (BLLN) at $140.21 ($0.56M total) on 2026-07-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Sakakibara Shan Riku
Published Aug 4, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BLLN
Neutral
high confidence
Mentioned
$BLLN
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BLLNNeutralLow
01

Why it matters

The newest fact is the specific open-market sale details (shares, price, total value) by the Chief Product Officer under a 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure reduces the likelihood of a fundamental negative catalyst.

03

What to watch

The filing does not disclose reasons for sale, and the net size ($560.8k) may be small relative to company fundamentals, limiting tradable inference.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-04, transaction dated 2026-07-31

Background

The article is an SEC Form 4 insider transaction disclosure for BillionToOne, Inc.

Company-level read

Ticker impact

$BLLNNeutralHigh confidence
Context

BillionToOne Form 4 shows CPO Sakakibara Shan Riku sold 4,000 shares at $140.21 under a 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect is more sentiment than fundamentals.

Evidence & confidence

The filing is an open-market sale by an officer under a pre-arranged 10b5-1 plan, with no accompanying operational or guidance change disclosed.

Market effects

No clear sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can be misread as bearish; a 10b5-1 plan often reflects scheduled diversification rather than negative expectations.

Key entities

  • BillionToOne, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Sakakibara Shan Riku

    Chief Product Officer who sold 4,000 shares under a 10b5-1 plan.

Related articles

$BLLNMedAI 8/10

BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move - BillionToOne (NASDAQ:BLLN)

BillionToOne (NASDAQ:BLLN) shares fell 28.12% in after-hours after reporting Q2 results. For the quarter ended June 30, 2026, revenue rose to $109.4M from $66.6M, net income was $8.1M ($0.15/share), and gross margin improved to 70%. The company kept 2026 revenue guidance of $450M to $465M and plans Unity Fetal Risk Screen (Aug. 17) and Northstar Origin (Sept. 1) launches.

$BLLNMedAI 8/10

Billiontoone (BLLN) – Research Analysts’ Recent Ratings Updates

BillionToOne (NASDAQ: BLLN) saw multiple analyst rating and target changes. Weiss Ratings upgraded BLLN to “sell (d+)” (from “sell (d)”) on 5/15 and reaffirmed “sell (d)” on 5/1. Guggenheim raised its target to $120 (from $100) and kept a “buy” on 5/13. JPMorgan lifted its target to $125 and maintained “overweight” on 5/7. BTIG cut its target to $130 (from $140) while keeping “buy” on 5/7.